TScan Therapeutics (TCRX) Announces Updates to its Board of Directors
Go back to TScan Therapeutics (TCRX) Announces Updates to its Board of Directors| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.76 -0.06 (7.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.82 | 52 Week High | $26.80 | |||
| Open | $0.77 | 52 Week Low | $23.00 | |||
| Day High | $0.82 | P/E | N/A | |||
| Day Low | $0.76 | EPS | $0.00 | |||
| Volume | 530,277 | |||||
